Skip to content

Prescribing medication in consideration of shared decision making and aspects of drug therapy

Prescribing medication in consideration of shared decision making and aspects of drug therapy - AMPEL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00008789
Enrollment
48
Registered
2015-10-01
Start date
2015-10-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E00-E90

Interventions

Group 1: medication prescription talk (routine clinical practice) Group 2: medication prescription talk (using the guide)

Sponsors

Institut für Pharmakologie der Universität zu Köln
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: consent to participating in the study; subject of consultation is either prescription of new medication or adjustment of preexisting pharmaco-therapy; Patients suffer from lipometabolic disorder and / or diabetes mellitus; minimum age 18 years; duration of therapy will be several weeks at least

Exclusion criteria

Exclusion criteria: limitation of linguistic, physical or cognitive functioning that could possibly preclude appropriate informing about the study or affect the prescribed medication therapy negatively; Patient initially refuses new prescription or adjustment of preexisting medication; new prescription or adjustment of preexisting medication are not subject of the actual conversation between patient and physician; the reason for the consultation is a therapy of an acute condition that will last less than two weeks

Design outcomes

Primary

MeasureTime frame
the guide's feasibility: is the guide feasible for clinical practice? Physicians will be surveyed by questionnaire after using the guide.

Secondary

MeasureTime frame
satisfaction (physicians): questionnaire before and after using the guide, Satisfaction (patients): questionnaires (SIMS-D, KPF-A) applied to interventional and control-patients

Countries

Germany

Contacts

Public ContactJan Matthes

Institut für Pharmakologie der Universität zu Köln

jan.matthes@uni-koeln.de0221 4785674

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026